Cargando…

Taxifolin Resensitizes Multidrug Resistance Cancer Cells via Uncompetitive Inhibition of P-Glycoprotein Function

P-glycoprotein (P-gp) effluxes lots of chemotherapeutic agents and leads to multidrug resistance (MDR) in cancer treatments. The development of P-gp inhibitors from natural products provide a potential strategy for the beneficial clinical outcomes. This study aimed to evaluate the effects of the nat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Hsiu-Ju, Chung, Yun-Lung, Li, Chia-Ying, Chang, Ying-Tzu, Wang, Charles C. N., Lee, Hsiang-Yen, Lin, Hui-Yi, Hung, Chin-Chuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321030/ https://www.ncbi.nlm.nih.gov/pubmed/30469543 http://dx.doi.org/10.3390/molecules23123055

Ejemplares similares

A mechanism of uncompetitive inhibition of the serotonin transporter
por: Bhat, Shreyas, et al.
Publicado: (2023)

Erdafitinib Resensitizes ABCB1-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs
por: Wu, Chung-Pu, et al.
Publicado: (2020)

Branebrutinib (BMS-986195), a Bruton’s Tyrosine Kinase Inhibitor, Resensitizes P-Glycoprotein-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Agents
por: Wu, Chung-Pu, et al.
Publicado: (2021)

Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline
por: Wang, Yuhang, et al.
Publicado: (2023)

Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
por: Lyu, Junhua, et al.
Publicado: (2023)

Mechanistic and Structural Understanding of Uncompetitive Inhibitors of Caspase-6
por: Heise, Christopher E., et al.
Publicado: (2012)

Resensitizing multidrug-resistant Gram-negative bacteria to carbapenems and colistin using disulfiram
por: Chen, Chen, et al.
Publicado: (2023)

Pinostrobin and Tectochrysin Conquer Multidrug-Resistant Cancer Cells via Inhibiting P-Glycoprotein ATPase
por: Wu, I-Ting, et al.
Publicado: (2023)

Metformin Resensitizes Sorafenib-Resistant HCC Cells Through AMPK-Dependent Autophagy Activation
por: Lai, Hong-Yue, et al.
Publicado: (2021)

Alternative Approach for Specific Tyrosinase Inhibitor Screening: Uncompetitive Inhibition of Tyrosinase by Moringa oleifera
por: Hashim, Farah J., et al.
Publicado: (2021)

Resensitizing AMPA receptors
por: Short, Ben
Publicado: (2019)

Discovery of uncompetitive inhibitors of SapM that compromise intracellular survival of Mycobacterium tuberculosis
por: Fernández-Soto, Paulina, et al.
Publicado: (2021)

Assembling the Puzzle of Taxifolin Polymorphism
por: Terekhov, Roman P., et al.
Publicado: (2020)

Resensitization in suspected penicillin allergy
por: Doña, Inmaculada, et al.
Publicado: (2022)

The Second-Generation PIM Kinase Inhibitor TP-3654 Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs
por: Wu, Chung-Pu, et al.
Publicado: (2021)

MicroRNA-631 Resensitizes Doxorubicin-Resistant Chondrosarcoma Cells by Targeting Apelin
por: Chen, Jui-Chieh, et al.
Publicado: (2023)

Calculation of statistic estimates of kinetic parameters from substrate uncompetitive inhibition equation using the median method
por: Valencia, Pedro L., et al.
Publicado: (2017)

Effects of Taxifolin on Osteoclastogenesis in vitro and in vivo
por: Cai, Cong, et al.
Publicado: (2018)

An insight into novel therapeutic potentials of taxifolin
por: Liu, Yang, et al.
Publicado: (2023)

Drug-Induced Hyperglycemia as a Potential Contributor to Translational Failure of Uncompetitive NMDA Receptor Antagonists
por: Wang, Eric Yuhsiang, et al.
Publicado: (2021)

Inhibition of HEWL fibril formation by taxifolin: Mechanism of action
por: Mahdavimehr, Mohsen, et al.
Publicado: (2017)

The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users
por: Shram, Megan J., et al.
Publicado: (2023)

The Selective Class IIa Histone Deacetylase Inhibitor TMP195 Resensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs
por: Wu, Chung-Pu, et al.
Publicado: (2019)

Crystal Structure of an SSB Protein from Salmonella enterica and Its Inhibition by Flavanonol Taxifolin
por: Lin, En-Shyh, et al.
Publicado: (2022)

Bradykinin increases resensitization of purinergic receptor signaling in glioma cells
por: López-Valdés, Héctor E, et al.
Publicado: (2010)

Ellagic Acid Resensitizes Gemcitabine-Resistant Bladder Cancer Cells by Inhibiting Epithelial-Mesenchymal Transition and Gemcitabine Transporters
por: Wu, Ying-Si, et al.
Publicado: (2021)

Benzothiazolyl Ureas are Low Micromolar and Uncompetitive Inhibitors of 17β-HSD10 with Implications to Alzheimer’s Disease Treatment
por: Schmidt, Monika, et al.
Publicado: (2020)

Fully human anti-CD39 antibody potently inhibits ATPase activity in cancer cells via uncompetitive allosteric mechanism
por: Spatola, Bradley N., et al.
Publicado: (2020)

Taxifolin as a Promising Ingredient of Cosmetics for Adult Skin
por: Micek, Iwona, et al.
Publicado: (2021)

Exploring Taxifolin Polymorphs: Insights on Hydrate and Anhydrous Forms
por: Stenger Moura, Fernanda Cristina, et al.
Publicado: (2021)

Orlistat Resensitizes Sorafenib-Resistance in Hepatocellular Carcinoma Cells through Modulating Metabolism
por: Shueng, Pei-Wei, et al.
Publicado: (2022)

Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide
por: Sun, Stella, et al.
Publicado: (2012)

Rewriting the Epigenetic Code for Tumor Resensitization: A Review
por: Oronsky, Bryan, et al.
Publicado: (2014)

Physiological Role of ATPase for GABA(A) Receptor Resensitization
por: Menzikov, Sergey A., et al.
Publicado: (2022)

ON THE MECHANISM OF ADAPTATION TO PROTEIN SYNTHESIS INHIBITORS BY TETRAHYMENA : Facilitation, Cross Adaptation, and Resensitization
por: Roberts, Charles T., et al.
Publicado: (1974)

Discovery of E2730, a novel selective uncompetitive GAT1 inhibitor, as a candidate for anti‐seizure medication
por: Fukushima, Kazuyuki, et al.
Publicado: (2023)

Astaxanthin inhibits gemcitabine-resistant human pancreatic cancer progression through EMT inhibition and gemcitabine resensitization
por: Yan, Tao, et al.
Publicado: (2017)

Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer
por: Davies, Gerald, et al.
Publicado: (2017)

Identification of Human Sulfotransferases Active towards Silymarin Flavonolignans and Taxifolin
por: Vrba, Jiří, et al.
Publicado: (2020)

Taxifolin: A Potential Therapeutic Agent for Cerebral Amyloid Angiopathy
por: Saito, Satoshi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jaart18rv60cl10fgrlf6gav0q